• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.48% Nasdaq Down0.45%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NasdaqCM
    2.12 Down 0.04(1.85%) 3:33PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 27,116   29,882   20,095  
    Cost of Revenue -   -   -  
    Gross Profit 27,116   29,882   20,095  
    Operating Expenses
    Research Development46,224  55,317  39,948  
    Selling General and Administrative10,625  9,892  7,791  
    Non Recurring(267) -  (1,657)
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (29,466) (35,327) (25,987)
    Income from Continuing Operations
    Total Other Income/Expenses Net3,226  3,478  4,889  
    Earnings Before Interest And Taxes(26,240)(31,849)(21,098)
    Interest Expense -   -   -  
    Income Before Tax(26,240)(31,849)(21,098)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(26,240)(31,849)(21,098)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (26,240) (31,849) (21,098)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (26,240) (31,849) (21,098)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.